- Article
- Source: Campus Sanofi
Vaxigrip Tetra Vial & Mexinvac: Las vacunas que protegen más allá de la INFLUENZA
Contexto sobre la eficacia y seguridad de Vaxigrip Tetra Vial & Mexinvac. Conoce más acerca de Vaxigrip Tetra & Mexinvac en su presentación de Vial multidosis, su eficacia y seguridad demostrada a lo largo de los años.
Referencias
Pepin S, Samson SI, Alvarez FP, et al. Impact of a quadrivalent inactivated influenza vaccine on influenza associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase Ill trial in the northern and southern hemispheres. Vaccine. 2019;37:1885-1888.
Frobert O, Gotberg M, Erlinge D, et al. Influenza vaccination after myocardial infarction: a randomized double-blind, placebo-controlled, multicenter trial. Circulation. 2021;144(18):1476-1484.
Duque J, Howe AS, Azziz-Baumgartner E, Petousis-Harris H. Multi-decade national cohort identifies adverse pregnancy and birth outcomes associated with acute respiratory illness hospitalisations during the influenza season. Influenza Other Respir Viruses. 2023;17(1):e13063.
Gresset-Bourgeois V, Leventhal PS, Pepin S, et al. Quadrivalent inactivated influenza vaccine (Vaxigrip Tetra™). Expert Rev Vaccines. 2018 Jan;17(1):1-11.
Macias AE, McElhaney JE, Chaves SS, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021 Mar 15;39 Suppl 1:A6-A14.
Warren-Gash C, Blackburn R, Whitaker H, et al. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland Eur Respir J. 2018 Mar 29;51(3):1701794.
Boehme AK, Luna J, Kulick ER, et al. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018 Mar 14;5(4):456-463.
Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018 Jan 25;378(4): 345-353.
Kubale J, Kuan G, Gresh L, et al. Individual-level Association of Influenza Infection With Subsequent Pneumonia: A Case-control and Prospective Cohort Study. Clin Infect Dis. 2021 Dec 6;73(11):e4288-e4295.
Samson SI, Konty K, Lee WN, et al. Quantifying the Impact of Influenza Among Persons With Type 2 Diabetes Mellitus: A New Approach to Determine Medical and Physical Activity Impact. J Diabetes Sci Technol. 2021 Jan;15(1):44-52.
Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza -- United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62.
Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012 May;54(10):1427-36.
Tisa V, Barberis I, Faccio V, et al. Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. J Prev Med Hyg. 2016;57(1):E28-33.
Vamos EP, Pape UJ, Curcin V, et al. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ. 2016 Oct 4;188(14):E342-E351.
Material exclusivo para el profesional de la salud